Global Beta Agonist Feed Additive Market Growth 2025-2031

December 2025 | 84 pages | ID: G50F01DBC550EN
LP Information

Abstracts

The global Beta Agonist Feed Additive market size is predicted to grow from US$ 272 million in 2025 to US$ 452 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Beta Agonist Feed Additive is a type of synthetic compound that mimics some of the effects of naturally-occurring substances by binding to beta-receptors on the surface of cells within the muscle, fat, and other tissues of animals. Beta Agonist Feed Additive is used to enhance lean muscle gain, increase growth rate, and improve feed efficiency in livestock, especially before slaughtering. There are two main types of Beta Agonist Feed Additive: ractopamine and zilpaterol, which are approved by the FDA for use in swine, turkeys, and cattle.

According to our Fee Research Center, in 2022, global total production of feed was about 1.2 billion tons. Key producing regions are Asia, Europe and North America, top ten countries hold about 65% of global feed production. China, United States, Brazil and India, as the top four countries, accounted for half of the total feed production.

LP Information, Inc. (LPI) ' newest research report, the “Beta Agonist Feed Additive Industry Forecast” looks at past sales and reviews total world Beta Agonist Feed Additive sales in 2024, providing a comprehensive analysis by region and market sector of projected Beta Agonist Feed Additive sales for 2025 through 2031. With Beta Agonist Feed Additive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta Agonist Feed Additive industry.

This Insight Report provides a comprehensive analysis of the global Beta Agonist Feed Additive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta Agonist Feed Additive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta Agonist Feed Additive market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta Agonist Feed Additive and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta Agonist Feed Additive.

This report presents a comprehensive overview, market shares, and growth opportunities of Beta Agonist Feed Additive market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Ractopamine
• Zilpaterol

Segmentation by Application:

• Swine
• Ruminants
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck Animal Health
• Elanco Animal Health
• Zoetis
• Quality Liquid Feeds
• Heer Pharma Private Limited

Key Questions Addressed in this Report

What is the 10-year outlook for the global Beta Agonist Feed Additive market?

What factors are driving Beta Agonist Feed Additive market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Beta Agonist Feed Additive market opportunities vary by end market size?

How does Beta Agonist Feed Additive break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Beta Agonist Feed Additive Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Beta Agonist Feed Additive by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Beta Agonist Feed Additive by Country/Region, 2020, 2024 & 2031
2.2 Beta Agonist Feed Additive Segment by Type
  2.2.1 Ractopamine
  2.2.2 Zilpaterol
2.3 Beta Agonist Feed Additive Sales by Type
  2.3.1 Global Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
  2.3.2 Global Beta Agonist Feed Additive Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Beta Agonist Feed Additive Sale Price by Type (2020-2025)
2.4 Beta Agonist Feed Additive Segment by Application
  2.4.1 Swine
  2.4.2 Ruminants
  2.4.3 Others
2.5 Beta Agonist Feed Additive Sales by Application
  2.5.1 Global Beta Agonist Feed Additive Sale Market Share by Application (2020-2025)
  2.5.2 Global Beta Agonist Feed Additive Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Beta Agonist Feed Additive Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Beta Agonist Feed Additive Breakdown Data by Company
  3.1.1 Global Beta Agonist Feed Additive Annual Sales by Company (2020-2025)
  3.1.2 Global Beta Agonist Feed Additive Sales Market Share by Company (2020-2025)
3.2 Global Beta Agonist Feed Additive Annual Revenue by Company (2020-2025)
  3.2.1 Global Beta Agonist Feed Additive Revenue by Company (2020-2025)
  3.2.2 Global Beta Agonist Feed Additive Revenue Market Share by Company (2020-2025)
3.3 Global Beta Agonist Feed Additive Sale Price by Company
3.4 Key Manufacturers Beta Agonist Feed Additive Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Beta Agonist Feed Additive Product Location Distribution
  3.4.2 Players Beta Agonist Feed Additive Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BETA AGONIST FEED ADDITIVE BY GEOGRAPHIC REGION

4.1 World Historic Beta Agonist Feed Additive Market Size by Geographic Region (2020-2025)
  4.1.1 Global Beta Agonist Feed Additive Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Beta Agonist Feed Additive Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Beta Agonist Feed Additive Market Size by Country/Region (2020-2025)
  4.2.1 Global Beta Agonist Feed Additive Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Beta Agonist Feed Additive Annual Revenue by Country/Region (2020-2025)
4.3 Americas Beta Agonist Feed Additive Sales Growth
4.4 APAC Beta Agonist Feed Additive Sales Growth
4.5 Europe Beta Agonist Feed Additive Sales Growth
4.6 Middle East & Africa Beta Agonist Feed Additive Sales Growth

5 AMERICAS

5.1 Americas Beta Agonist Feed Additive Sales by Country
  5.1.1 Americas Beta Agonist Feed Additive Sales by Country (2020-2025)
  5.1.2 Americas Beta Agonist Feed Additive Revenue by Country (2020-2025)
5.2 Americas Beta Agonist Feed Additive Sales by Type (2020-2025)
5.3 Americas Beta Agonist Feed Additive Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Beta Agonist Feed Additive Sales by Region
  6.1.1 APAC Beta Agonist Feed Additive Sales by Region (2020-2025)
  6.1.2 APAC Beta Agonist Feed Additive Revenue by Region (2020-2025)
6.2 APAC Beta Agonist Feed Additive Sales by Type (2020-2025)
6.3 APAC Beta Agonist Feed Additive Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Beta Agonist Feed Additive by Country
  7.1.1 Europe Beta Agonist Feed Additive Sales by Country (2020-2025)
  7.1.2 Europe Beta Agonist Feed Additive Revenue by Country (2020-2025)
7.2 Europe Beta Agonist Feed Additive Sales by Type (2020-2025)
7.3 Europe Beta Agonist Feed Additive Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Beta Agonist Feed Additive by Country
  8.1.1 Middle East & Africa Beta Agonist Feed Additive Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Beta Agonist Feed Additive Revenue by Country (2020-2025)
8.2 Middle East & Africa Beta Agonist Feed Additive Sales by Type (2020-2025)
8.3 Middle East & Africa Beta Agonist Feed Additive Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta Agonist Feed Additive
10.3 Manufacturing Process Analysis of Beta Agonist Feed Additive
10.4 Industry Chain Structure of Beta Agonist Feed Additive

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Beta Agonist Feed Additive Distributors
11.3 Beta Agonist Feed Additive Customer

12 WORLD FORECAST REVIEW FOR BETA AGONIST FEED ADDITIVE BY GEOGRAPHIC REGION

12.1 Global Beta Agonist Feed Additive Market Size Forecast by Region
  12.1.1 Global Beta Agonist Feed Additive Forecast by Region (2026-2031)
  12.1.2 Global Beta Agonist Feed Additive Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Beta Agonist Feed Additive Forecast by Type (2026-2031)
12.7 Global Beta Agonist Feed Additive Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck Animal Health
  13.1.1 Merck Animal Health Company Information
  13.1.2 Merck Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
  13.1.3 Merck Animal Health Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Animal Health Main Business Overview
  13.1.5 Merck Animal Health Latest Developments
13.2 Elanco Animal Health
  13.2.1 Elanco Animal Health Company Information
  13.2.2 Elanco Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
  13.2.3 Elanco Animal Health Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Elanco Animal Health Main Business Overview
  13.2.5 Elanco Animal Health Latest Developments
13.3 Zoetis
  13.3.1 Zoetis Company Information
  13.3.2 Zoetis Beta Agonist Feed Additive Product Portfolios and Specifications
  13.3.3 Zoetis Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Zoetis Main Business Overview
  13.3.5 Zoetis Latest Developments
13.4 Quality Liquid Feeds
  13.4.1 Quality Liquid Feeds Company Information
  13.4.2 Quality Liquid Feeds Beta Agonist Feed Additive Product Portfolios and Specifications
  13.4.3 Quality Liquid Feeds Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Quality Liquid Feeds Main Business Overview
  13.4.5 Quality Liquid Feeds Latest Developments
13.5 Heer Pharma Private Limited
  13.5.1 Heer Pharma Private Limited Company Information
  13.5.2 Heer Pharma Private Limited Beta Agonist Feed Additive Product Portfolios and Specifications
  13.5.3 Heer Pharma Private Limited Beta Agonist Feed Additive Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Heer Pharma Private Limited Main Business Overview
  13.5.5 Heer Pharma Private Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Beta Agonist Feed Additive Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Beta Agonist Feed Additive Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ractopamine
Table 4. Major Players of Zilpaterol
Table 5. Global Beta Agonist Feed Additive Sales by Type (2020-2025) & (Tons)
Table 6. Global Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
Table 7. Global Beta Agonist Feed Additive Revenue by Type (2020-2025) & ($ million)
Table 8. Global Beta Agonist Feed Additive Revenue Market Share by Type (2020-2025)
Table 9. Global Beta Agonist Feed Additive Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Beta Agonist Feed Additive Sale by Application (2020-2025) & (Tons)
Table 11. Global Beta Agonist Feed Additive Sale Market Share by Application (2020-2025)
Table 12. Global Beta Agonist Feed Additive Revenue by Application (2020-2025) & ($ million)
Table 13. Global Beta Agonist Feed Additive Revenue Market Share by Application (2020-2025)
Table 14. Global Beta Agonist Feed Additive Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Beta Agonist Feed Additive Sales by Company (2020-2025) & (Tons)
Table 16. Global Beta Agonist Feed Additive Sales Market Share by Company (2020-2025)
Table 17. Global Beta Agonist Feed Additive Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Beta Agonist Feed Additive Revenue Market Share by Company (2020-2025)
Table 19. Global Beta Agonist Feed Additive Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Beta Agonist Feed Additive Producing Area Distribution and Sales Area
Table 21. Players Beta Agonist Feed Additive Products Offered
Table 22. Beta Agonist Feed Additive Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Beta Agonist Feed Additive Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Beta Agonist Feed Additive Sales Market Share Geographic Region (2020-2025)
Table 27. Global Beta Agonist Feed Additive Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Beta Agonist Feed Additive Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Beta Agonist Feed Additive Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Beta Agonist Feed Additive Sales Market Share by Country/Region (2020-2025)
Table 31. Global Beta Agonist Feed Additive Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Beta Agonist Feed Additive Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Beta Agonist Feed Additive Sales by Country (2020-2025) & (Tons)
Table 34. Americas Beta Agonist Feed Additive Sales Market Share by Country (2020-2025)
Table 35. Americas Beta Agonist Feed Additive Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Beta Agonist Feed Additive Sales by Type (2020-2025) & (Tons)
Table 37. Americas Beta Agonist Feed Additive Sales by Application (2020-2025) & (Tons)
Table 38. APAC Beta Agonist Feed Additive Sales by Region (2020-2025) & (Tons)
Table 39. APAC Beta Agonist Feed Additive Sales Market Share by Region (2020-2025)
Table 40. APAC Beta Agonist Feed Additive Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Beta Agonist Feed Additive Sales by Type (2020-2025) & (Tons)
Table 42. APAC Beta Agonist Feed Additive Sales by Application (2020-2025) & (Tons)
Table 43. Europe Beta Agonist Feed Additive Sales by Country (2020-2025) & (Tons)
Table 44. Europe Beta Agonist Feed Additive Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Beta Agonist Feed Additive Sales by Type (2020-2025) & (Tons)
Table 46. Europe Beta Agonist Feed Additive Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Beta Agonist Feed Additive Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Beta Agonist Feed Additive Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Beta Agonist Feed Additive Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Beta Agonist Feed Additive Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Beta Agonist Feed Additive
Table 52. Key Market Challenges & Risks of Beta Agonist Feed Additive
Table 53. Key Industry Trends of Beta Agonist Feed Additive
Table 54. Beta Agonist Feed Additive Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Beta Agonist Feed Additive Distributors List
Table 57. Beta Agonist Feed Additive Customer List
Table 58. Global Beta Agonist Feed Additive Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Beta Agonist Feed Additive Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Beta Agonist Feed Additive Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Beta Agonist Feed Additive Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Beta Agonist Feed Additive Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Beta Agonist Feed Additive Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Beta Agonist Feed Additive Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Beta Agonist Feed Additive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Beta Agonist Feed Additive Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Beta Agonist Feed Additive Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Beta Agonist Feed Additive Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Beta Agonist Feed Additive Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Beta Agonist Feed Additive Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Beta Agonist Feed Additive Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Animal Health Basic Information, Beta Agonist Feed Additive Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
Table 74. Merck Animal Health Beta Agonist Feed Additive Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Merck Animal Health Main Business
Table 76. Merck Animal Health Latest Developments
Table 77. Elanco Animal Health Basic Information, Beta Agonist Feed Additive Manufacturing Base, Sales Area and Its Competitors
Table 78. Elanco Animal Health Beta Agonist Feed Additive Product Portfolios and Specifications
Table 79. Elanco Animal Health Beta Agonist Feed Additive Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Elanco Animal Health Main Business
Table 81. Elanco Animal Health Latest Developments
Table 82. Zoetis Basic Information, Beta Agonist Feed Additive Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Beta Agonist Feed Additive Product Portfolios and Specifications
Table 84. Zoetis Beta Agonist Feed Additive Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. Quality Liquid Feeds Basic Information, Beta Agonist Feed Additive Manufacturing Base, Sales Area and Its Competitors
Table 88. Quality Liquid Feeds Beta Agonist Feed Additive Product Portfolios and Specifications
Table 89. Quality Liquid Feeds Beta Agonist Feed Additive Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Quality Liquid Feeds Main Business
Table 91. Quality Liquid Feeds Latest Developments
Table 92. Heer Pharma Private Limited Basic Information, Beta Agonist Feed Additive Manufacturing Base, Sales Area and Its Competitors
Table 93. Heer Pharma Private Limited Beta Agonist Feed Additive Product Portfolios and Specifications
Table 94. Heer Pharma Private Limited Beta Agonist Feed Additive Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Heer Pharma Private Limited Main Business
Table 96. Heer Pharma Private Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Beta Agonist Feed Additive
Figure 2. Beta Agonist Feed Additive Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta Agonist Feed Additive Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Beta Agonist Feed Additive Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Beta Agonist Feed Additive Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Beta Agonist Feed Additive Sales Market Share by Country/Region (2024)
Figure 10. Beta Agonist Feed Additive Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ractopamine
Figure 12. Product Picture of Zilpaterol
Figure 13. Global Beta Agonist Feed Additive Sales Market Share by Type in 2025
Figure 14. Global Beta Agonist Feed Additive Revenue Market Share by Type (2020-2025)
Figure 15. Beta Agonist Feed Additive Consumed in Swine
Figure 16. Global Beta Agonist Feed Additive Market: Swine (2020-2025) & (Tons)
Figure 17. Beta Agonist Feed Additive Consumed in Ruminants
Figure 18. Global Beta Agonist Feed Additive Market: Ruminants (2020-2025) & (Tons)
Figure 19. Beta Agonist Feed Additive Consumed in Others
Figure 20. Global Beta Agonist Feed Additive Market: Others (2020-2025) & (Tons)
Figure 21. Global Beta Agonist Feed Additive Sale Market Share by Application (2024)
Figure 22. Global Beta Agonist Feed Additive Revenue Market Share by Application in 2025
Figure 23. Beta Agonist Feed Additive Sales by Company in 2025 (Tons)
Figure 24. Global Beta Agonist Feed Additive Sales Market Share by Company in 2025
Figure 25. Beta Agonist Feed Additive Revenue by Company in 2025 ($ millions)
Figure 26. Global Beta Agonist Feed Additive Revenue Market Share by Company in 2025
Figure 27. Global Beta Agonist Feed Additive Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Beta Agonist Feed Additive Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Beta Agonist Feed Additive Sales 2020-2025 (Tons)
Figure 30. Americas Beta Agonist Feed Additive Revenue 2020-2025 ($ millions)
Figure 31. APAC Beta Agonist Feed Additive Sales 2020-2025 (Tons)
Figure 32. APAC Beta Agonist Feed Additive Revenue 2020-2025 ($ millions)
Figure 33. Europe Beta Agonist Feed Additive Sales 2020-2025 (Tons)
Figure 34. Europe Beta Agonist Feed Additive Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Beta Agonist Feed Additive Sales 2020-2025 (Tons)
Figure 36. Middle East & Africa Beta Agonist Feed Additive Revenue 2020-2025 ($ millions)
Figure 37. Americas Beta Agonist Feed Additive Sales Market Share by Country in 2025
Figure 38. Americas Beta Agonist Feed Additive Revenue Market Share by Country (2020-2025)
Figure 39. Americas Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
Figure 40. Americas Beta Agonist Feed Additive Sales Market Share by Application (2020-2025)
Figure 41. United States Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Beta Agonist Feed Additive Sales Market Share by Region in 2025
Figure 46. APAC Beta Agonist Feed Additive Revenue Market Share by Region (2020-2025)
Figure 47. APAC Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
Figure 48. APAC Beta Agonist Feed Additive Sales Market Share by Application (2020-2025)
Figure 49. China Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 53. India Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Beta Agonist Feed Additive Sales Market Share by Country in 2025
Figure 57. Europe Beta Agonist Feed Additive Revenue Market Share by Country (2020-2025)
Figure 58. Europe Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
Figure 59. Europe Beta Agonist Feed Additive Sales Market Share by Application (2020-2025)
Figure 60. Germany Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 61. France Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Beta Agonist Feed Additive Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Beta Agonist Feed Additive Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Beta Agonist Feed Additive Sales Market Share by Application (2020-2025)
Figure 68. Egypt Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Beta Agonist Feed Additive Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Beta Agonist Feed Additive in 2025
Figure 74. Manufacturing Process Analysis of Beta Agonist Feed Additive
Figure 75. Industry Chain Structure of Beta Agonist Feed Additive
Figure 76. Channels of Distribution
Figure 77. Global Beta Agonist Feed Additive Sales Market Forecast by Region (2026-2031)
Figure 78. Global Beta Agonist Feed Additive Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Beta Agonist Feed Additive Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Beta Agonist Feed Additive Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Beta Agonist Feed Additive Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Beta Agonist Feed Additive Revenue Market Share Forecast by Application (2026-2031)